Article Details

Leerink Partners Keeps a Buy Rating on Viking Therapeutics (VKTX)

Retrieved on: 2021-05-03 07:30:00

Tags for this article:

Click the tags to see associated articles and topics

Leerink Partners Keeps a Buy Rating on Viking Therapeutics (VKTX). View article details on hiswai:

Excerpt

Smith covers the Healthcare sector, focusing on stocks such as Connect Biopharma Holdings, Madrigal Pharmaceuticals, and Eledon Pharmaceuticals.

Article found on: www.smarteranalyst.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up